Elanco stock: Company authorizes USD 600 million buyback
Published on 11/20/2026 at 22:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSElanco expands capital returns
- The board authorized Elanco's first share-repurchase program after net leverage fell below 3.0 times adjusted EBITDA.
- Management said the company is targeting net leverage of 2.0 to 2.5 times while continuing debt reduction and investment in innovation.
- Free cash flow reached USD 362 million through the third quarter against a cumulative 2026-2028 target of USD 1 billion.
Elanco Animal Health announced on Thursday, November 19, that its board had authorized the repurchase of up to USD 600 million of common stock. The company described the authorization as its first share-repurchase program. The announcement was carried by PR Newswire.
The program is planned as a multi-year capital-return measure alongside debt reduction and investment in innovation. Elanco said the timing, method and amount of purchases will depend on market conditions, the stock price, alternative uses of capital and regulatory requirements. The authorization does not require the company to buy a specific number of shares or spend the full amount.
Leverage gives capital flexibility
Elanco said its net leverage ratio had fallen below 3.0 times adjusted EBITDA ahead of schedule. Management described a longer-term path toward net leverage of 2.0 to 2.5 times and said the stronger balance sheet supports a more balanced capital-allocation framework.
Free cash flow reached USD 362 million at the end of the third quarter, according to the company. Elanco is targeting cumulative free cash flow of USD 1 billion from 2026 through 2028 while continuing to fund growth initiatives and its product pipeline.
Quote reflects late session
Elanco stock traded at 23.49 euros on Lang & Schwarz at 22:01 CET on Friday, November 20, 2026.
Elanco Animal Health
- Company: Elanco Animal Health Incorporated
- Ticker: ELAN
- Primary exchange: New York Stock Exchange
- Lang & Schwarz quote: 23.49 euros on November 20, 2026, at 22:01 CET
- Repurchase authorization: Up to USD 600 million
The broader market context is covered in current S&P 500 market reports.
